Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
28.04.23
/
50%
€8.85
Target price
28.04.24
€21.78
Performance (%)
28.81%
End price
29.04.24
€11.40
Summary
This prediction ended on 29.04.24 with a price of €11.40. The prediction had a final performance of 28.81%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Stoke Therapeutics Inc | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten